Adam S. Tenforde

Dr. Adam S. Tenforde

PM&R, Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
JWJan Wilke
Jan Wilke
LMLisa Mohr
Lisa Mohr
Adam S. TenfordeAdam S. Tenforde
Adam S. Tenforde
Pascal EdouardPascal Edouard
Pascal Edouard
CFChiara Fossati
Chiara Fossati
KHKarsten Hollander
Karsten Hollander
Governments have restricted public life during the COVID-19 pandemic, inter alia closing sports facilities and gyms. As regular exercise is essential for health, this study examined the effect of pandemic-related confinements on physical activity (PA) levels. A multinational survey was performed in 14 countries. Times spent in moderate-to-vigorous physical activity (MVPA) as well as in vigorous physical activity only (VPA) were assessed using the Nordic Physical Activity Questionnaire (short form). Data were obtained for leisure and occupational PA pre- and during restrictions. Compliance with PA guidelines was calculated based on the recommendations of the World Health Organization (WHO). In total, n = 13,503 respondents (39 ± 15 years, 59% females) were surveyed. Compared to pre-restrictions, overall self-reported PA declined by 41% (MVPA) and 42.2% (VPA). Reductions were higher for occupational vs. leisure time, young and old vs. middle-aged persons, previously more active vs. less active individuals, but similar between men and women. Compared to pre-pandemic, compliance with WHO guidelines decreased from 80.9% (95% CI: 80.3–81.7) to 62.5% (95% CI: 61.6–63.3). Results suggest PA levels have substantially decreased globally during the COVID-19 pandemic. Key stakeholders should consider strategies to mitigate loss in PA in order to preserve health during the pandemic.

18 May 2017 in PM&R
Verified
Journal Article
Closed access
Adam S. TenfordeAdam S. Tenforde
Adam S. Tenforde
JHJaye E. Hefner
Jaye E. Hefner
JKJodi E. Kodish‐Wachs
Jodi E. Kodish‐Wachs
MIMary A. Iaccarino
Mary A. Iaccarino
SPSabrina Paganoni
Sabrina Paganoni

28 April 2022 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
THTim Hoenig
Tim Hoenig
KAKathryn Ackerman
Kathryn Ackerman
BBBelinda Beck
Belinda Beck
MBMary L. Bouxsein
Mary L. Bouxsein
DBDavid B. Burr
David B. Burr
SWStuart J. Warden
Stuart J. Warden

24 November 2021 in Life
Verified
Journal Article
Open access
PDF file
HRHye Chang Rhim
Hye Chang Rhim
JKJangwon Kwon
Jangwon Kwon
JPJewel Park
Jewel Park
JBJoanne Borg-Stein
Joanne Borg-Stein
Adam S. TenfordeAdam S. Tenforde
Adam S. Tenforde
The number of systematic review and meta-analyses on plantar fasciitis is expanding. The purpose of this review was to provide a comprehensive summary of reviews on the topic pertaining to plantar fasciitis, identify any conflicting and inconsistent results, and propose future research direction. A qualitative review of all systematic reviews and meta-analyses related to plantar fasciitis up to February 2021 was performed using PubMed, Embase, Web of Science, and the Cochrane Database. A total of 1052 articles were initially identified and 96 met the inclusion criteria. Included articles were summarized and divided into the following topics: epidemiology, diagnosis, and treatment. While the majority of reviews had high level of heterogeneity and included a small number of studies, there was general consensus on certain topics, such as BMI as a risk factor for plantar fasciitis and extracorporeal shockwave therapy as an effective mode of therapy. A qualitative summary of systematic reviews and meta-analyses published on plantar fasciitis provides a single source of updated information for clinicians. Evidence on topics such as the epidemiology, exercise therapy, or cost-effectiveness of treatment options for plantar fasciitis are lacking and warrant future research.

18 May 2020 in PM&R
Verified
Journal Article
Closed access
PDF file
Adam S. TenfordeAdam S. Tenforde
Adam S. Tenforde
MIMary A. Iaccarino
Mary A. Iaccarino
HBHaylee Borgstrom
Haylee Borgstrom
JHJaye E. Hefner
Jaye E. Hefner
JSJulie Silver
Julie Silver
JBJoanne Borg‐Stein
Joanne Borg‐Stein

1 December 2018 in PM&R
Verified
Journal Article
Open access
JRJulia M. Reilly
Julia M. Reilly
EBEric Bluman
Eric Bluman
Adam S. TenfordeAdam S. Tenforde
Adam S. Tenforde
Extracorporeal shockwave therapy (ESWT) is a technology that was first introduced into clinical practice in 1982 for urologic conditions. Subsequent clinical applications in musculoskeletal conditions have been described in treatment of plantar fasciopathy, both upper and lower extremity tendinopathies, greater trochanteric pain syndrome, medial tibial stress syndrome, management of nonunion fractures, and joint disease including avascular necrosis. The aim of this review is to summarize the current understanding of treatment of musculoskeletal conditions with ESWT, accounting for differences in treatment protocol and energy levels. Complications from ESWT are rare but include 2 reported cases of injury to bone and Achilles tendon rupture in older adults using focused shockwave. Collectively, studies suggest ESWT is generally well‐tolerated treatment strategy for multiple musculoskeletal conditions commonly seen in clinical practice.Level of Evidence: III